@InnovationFixer@ScienceofPD Anyone know who has licensing rights to eltoprazine, a Phase 2b-ready small molecule indicated for Parkinson's disease levodopa-induced dyskinesia now that Amarantus BioScience has gone bust? 2b Results were good. Thanks
Really well written Simon, thanks https://t.co/siy6fkPOyU surprised the bridge study was not published as I would like to look at data more closely https://t.co/zkeII9gdRE fyi corp deck: https://t.co/3RQj08oWkV
@TalkNorwichCity@JackReeveTNC@ChrisReevo When are football clubs going to put a 6 month clause in their manager contracts!? I honestly think he would rather be sacked. Complete shambles
@ScienceofPD Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging https://t.co/kozsAuSCaU
@ScienceofPD Best dose?! Is that the encapsulated or 3D cultured version as we know ~90% of these cells are dying after transplantation? Anyone researching or commentating why this is happening? Guessing inflammation/ECM microenvironment/cells just not happy after being outside the dish. Ty